SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-043101
Filing Date
2019-11-13
Accepted
2019-11-13 08:11:25
Documents
55
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 ALLENA 10-Q SEPTEMBER 2019 alna-10q_20190930.htm 10-Q 2098858
2 EX-10.1 alna-ex101_41.htm EX-10.1 363201
3 EX-31.1 alna-ex311_7.htm EX-31.1 17100
4 EX-31.2 alna-ex312_6.htm EX-31.2 17149
5 EX-32.1 alna-ex321_8.htm EX-32.1 10211
  Complete submission text file 0001564590-19-043101.txt   5692468

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alna-20190930.xml EX-101.INS 866099
7 XBRL TAXONOMY EXTENSION SCHEMA alna-20190930.xsd EX-101.SCH 37156
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alna-20190930_cal.xml EX-101.CAL 38802
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alna-20190930_def.xml EX-101.DEF 121746
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alna-20190930_lab.xml EX-101.LAB 310702
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alna-20190930_pre.xml EX-101.PRE 232477
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38268 | Film No.: 191211735
SIC: 2836 Biological Products, (No Diagnostic Substances)